In MM, BCL2L10 overexpression is clearly associated with apoptosis inhibition since BCL2L10 knockdown by specific siRNA or targeting BCL2L10 function by a small peptidomimetic consistently increased cell death[19], in good agreement with our own findings. The gene discussed is BCL2L10; the disease is Miyoshi myopathy.